Adrian Adams
2020 - IMPEL PHARMACEUTICALS
In 2020, Adrian Adams earned a total compensation of $3.7M as Chief Executive Officer and President at IMPEL PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $95,544 |
|---|---|
| Option Awards | $3,348,910 |
| Salary | $266,041 |
| Other | $15,330 |
| Total | $3,725,825 |
Adams received $3.3M in option awards, accounting for 90% of the total pay in 2020.
Adams also received $95.5K in non-equity incentive plan, $266K in salary and $15.3K in other compensation.
Rankings
In 2020, Adrian Adams' compensation ranked 3,102nd out of 13,090 executives tracked by ExecPay. In other words, Adams earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,102 out of 13,090 | 76th |
Division Manufacturing | 1,207 out of 5,617 | 79th |
Major group Chemicals And Allied Products | 460 out of 2,248 | 80th |
Industry group Drugs | 398 out of 1,948 | 80th |
Industry Pharmaceutical Preparations | 297 out of 1,453 | 80th |
Source: SEC filing on April 26, 2022.
Adams' colleagues
We found one more compensation record of an executive who worked with Adrian Adams at IMPEL PHARMACEUTICALS in 2020.
2020
John Leaman
IMPEL PHARMACEUTICALS